期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
High Prevalence of Multidrug Resistant <i>Klebsiella</i>Species Isolated from the Yaounde University Teaching Hospital, Cameroon
1
作者 Emilia Enjema Lyonga Mbamyah Florence Anjabie Enyeji +10 位作者 Judith Torimiro patience mangum Modestine Djuissi Aime-Caesar Teukam Martha Tongo Mesembe George Mondinde Ikomey Anicette Chafa Betbeui Dieudonné Sedena William Baiye Agnes Bedie Eyoh Hortense Kamga Gonsu 《Open Journal of Medical Microbiology》 2021年第2期91-99,共9页
<b><span style="font-family:Verdana;">Background and Purpose: </span></b><i><span style="font-family:Verdana;">Klebsiella</span></i><span style=&q... <b><span style="font-family:Verdana;">Background and Purpose: </span></b><i><span style="font-family:Verdana;">Klebsiella</span></i><span style="font-family:""><span style="font-family:Verdana;"> species are amongst the most common causes of a variety of community-acquired and hospital-acquired infections (HAI), characterized by high morbidity and mortality rates. Most infections caused by </span><i><span style="font-family:Verdana;">Klebsiella</span></i><span style="font-family:Verdana;"> species are usually treated using antibiotics. The aim of this study was to determine the antimicrobial resistance profile of </span><i><span style="font-family:Verdana;">Klebsiella</span></i><span style="font-family:Verdana;"> species isolated from in-patients and out-patients at the Yaounde University Teaching Hospital. The data generated will go a long way to improve on the choice of an adequate empiric antibiotic treatment for infections caused by </span><i><span style="font-family:Verdana;">Klebsiella</span></i><span style="font-family:Verdana;"> species. </span><b><span style="font-family:Verdana;">Methodology: </span></b><span style="font-family:Verdana;">A cross</span></span><span style="font-family:Verdana;">-</span><span style="font-family:""><span style="font-family:Verdana;">sectional descriptive study was carried out over a period of 6 months, spanning from February 2019 to July 2019 with a sample size of 37 isolates, obtained from 6 different clinical specimens. Identification of isolates was done using API 20E identification system (Bio</span><span style="font-family:Verdana;">merieux SA, Lyon, France). Susceptibility to antibiotics was tested as de</span><span style="font-family:Verdana;">scribed by Kirby-Bauer in 1956. Inhibition diameters were interpreted according to recommendations from the European Committee on Antimicrobial Suscepti</span><span><span style="font-family:Verdana;">bility Testing (EUCAST, 2019). </span><b><span style="font-family:Verdana;">Results and Conclusion: </span></b><span style="font-family:Verdana;">Among the 37</span></span> <i><span style="font-family:Verdana;">Klebsiella</span></i><span style="font-family:Verdana;"> isolates identified, </span><i><span style="font-family:Verdana;">Klebsiella pneumoniae</span></i><span style="font-family:Verdana;"> was the most prevalent species isolated with a percentage of 54.1%, followed by </span><i><span style="font-family:Verdana;">Klebsiella rhinoscleromatis</span></i><span style="font-family:Verdana;"> 18.9%, </span><i><span style="font-family:Verdana;">Klebsiella ozaenae </span></i><span style="font-family:Verdana;">16.2% and </span><i><span style="font-family:Verdana;">Klebsiella oxytoca</span></i><span style="font-family:Verdana;">, 10.8%. The resistance pattern of </span><i><span style="font-family:Verdana;">Klebsiella</span></i><span style="font-family:Verdana;"> to amoxicillin, amoxicillin/clavulanate, tircacillin, tircacillin + clavulanic acid, piperacillin, piperacillin + tazobactam, cefalotin, cefuroxim, ceftazidime, cefotaxime, ceftriaxone, cefepime, imipenem, meropenem, aztreonam, amikacin, gentamicin, tobramycin, trimethoprim/</span></span><span style="font-family:""> </span><span style="font-family:Verdana;">sulfamethoxazole, nalidixic acid, pipemidic acid, norfloxacin, ciprofloxacin, levofloxacin, ofloxacin, and moxifoxacin was as follows;100%, 86.5%, 97.3%, 83.6%, 86.5%, 16.2%, 86.5%, 83.8%, 78.4%, 32.4%, 78.4%, 76.7%, 2.7%, 2.7%,</span><span style="font-family:""> </span><span style="font-family:Verdana;">76.7%,</span><span style="font-family:""> </span><span style="font-family:Verdana;">13.5%,</span><span style="font-family:""> </span><span style="font-family:Verdana;">75.7%,</span><span style="font-family:""> </span><span style="font-family:Verdana;">73.0%, 91.9%, 51.4%, 48.6%, 64.9%, 48.6%, 48.6%, 73.0% and </span><span style="font-family:""><span style="font-family:Verdana;">62.2% respectively. Multidrug resistance was observed in 94.6% of the </span><i><span style="font-family:Verdana;">Klebsiella</span></i><span style="font-family:Verdana;"> isolates. </span><b><span style="font-family:Verdana;">Conclusion: </span></b><span style="font-family:Verdana;">This study shows that the level of multidrug resistance is high. The isolates expressed good sensitivity to carbapenems, piperacillin + tazobactam, amikacin and high resistance to all other antimicrobials tested. Therefore, antimicrobial susceptibility test</span><span style="font-family:Verdana;">ing prior to prescriptions should be encouraged and sensitization of the population about consequences of inappropriate antibiotic treatment and auto medication should be enforced as a mean</span></span><span style="font-family:Verdana;">s</span><span style="font-family:Verdana;"> to curb antimicrobial resistance</span><span style="font-family:Verdana;">. 展开更多
关键词 Klebsiella Species Antimicrobial Resistance Multidrug Resistance
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部